Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases
- 29 February 2008
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Pharmacology
- Vol. 8 (1), 8-13
- https://doi.org/10.1016/j.coph.2007.09.009
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Endotoxin Preconditioning Protects against the Cytotoxic Effects of TNFα after Stroke: A Novel Role for TNFα in LPS-Ischemic ToleranceJournal of Cerebral Blood Flow & Metabolism, 2007
- Endotoxin Preconditioning Prevents Cellular Inflammatory Response During Ischemic Neuroprotection in MiceStroke, 2004
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRsThe Journal of Immunology, 2004
- LPS-Induced Upregulation of SHIP Is Essential for Endotoxin ToleranceImmunity, 2004
- mRNA Is an Endogenous Ligand for Toll-like Receptor 3Journal of Biological Chemistry, 2004
- Interferon-Beta Blocks Infiltration of Inflammatory Cells and Reduces Infarct Volume after Ischemic Stroke in the RatJournal of Cerebral Blood Flow & Metabolism, 2003
- TNF-α pretreatment prevents subsequent activation of cultured brain cells with TNF-α and hypoxia via ceramideAmerican Journal of Physiology-Cell Physiology, 1999
- Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive ratsBrain Research, 1997
- Induction of 70-kDa Heat Shock Protein and hsp70 mRNA following Transient Focal Cerebral Ischemia in the RatJournal of Cerebral Blood Flow & Metabolism, 1993